Hematology - Hematology Xagena

Hematology

News

Drugs

Xagena Medicine

Xagena.net

Anemia associated with higher risk of death in the elderly

CD19 monoclonal antibody could treat leukemias, autoimmune diseases, transplant rejection

Heme controls antioxidants and iron in ferritin

FDA Panel recommends approval of Exjade for once-daily oral treatment of chronic iron overload due to blood transfusions

KLF2 protein is crucial for normal development and regulation of red blood cells

AML patients with 8;21 translocation: need for different therapy

Multiple myeloma, Revlimid and Dexamethasone show promise

Anemia, new route to hemoglobin synthesis discovered

Multiple myeloma, Thalidomide is better than conventional chemotherapy

Sickle cell anemia, oral liquid Hydroxyurea promising for long-term use

Relapsed multiple myeloma, Velcade is superior to high-dose Dexamethasone

Galiximab and Rituxan may extend event-free survival in patients with relapsed or refractory, follicular lymphoma

Hemophilia, gene therapy produces partial correction to bleeding problems in mouse models

Mantle cell lymphoma, an experimental vaccine can prime the immune system

Fanconi anemia, BRIP1 mutations may have a role in development of the disease

Multiple myeloma, potential role of Velcade as frontline therapy

Alcohol may lower risk of non-Hodgkin’s lymphoma

Revlimid in low and intermediate-1 risk myelodysplastic syndromes

Novel combination overcomes drug-resistant myeloma cells

Increased risk of leukemia for children close to power lines at birth

HEIRS study, Asians and Pacific Islanders have the highest levels of iron

Notch a key regulator of hematopoietic stem cells

Revlimid, clinical benefits in patients with relapsed or refractory multiple myeloma

Chronic lymphocytic leucemia, MRD-negative remission with Alemtuzumab improves survival

Multiple myeloma, EU approves Velcade as a second-line treatment

Exposure to infections in early life protects against childhood leukemia

Bortezomib approved for second-line multiple myeloma

Role of anti-hepatitis C virus treatment in patients with B-cell non-Hodgkin's lymphoma and HCV infection

Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin’s lymphoma

Bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

Next Pages 1 [2] 3

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions